Novel Antifungals by Engineering the AbA NRPS gene

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$162,982.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43AI061864-01
Agency Tracking Number:
AI061864
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
AUREOGEN BIOSCIENCES, INC.
4717 CAMPUS DRIVE, SUITE 1200, KALAMAZOO, MI, 49008
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
AKE Elhammer
(269) 372-3517
AKE.P.ELHAMMER@AUREOGEN.COM
Business Contact:
(269) 372-3517
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): There is an immediate need for efficient, novel antifungal drugs. The fungus Aureobasidium pullulans produces a cyclic peptide know as Aureobasidin A (AbA) which is a very potent, fungicidal drug that is currently bar

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government